Podcast Episode Details
Back to Podcast Episodes
How Bristol Myers Squibb Is Accelerating Drug Development With AI
Episode 264
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
Published on 1 month, 2 weeks ago